Tertiary Minerals plc (AIM:TYM)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 4.64M |
| Revenue (ttm) | 200.57K |
| Net Income (ttm) | -583.92K |
| Shares Out | 5.15B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 95,020,999 |
| Average Volume | 44,644,849 |
| Open | 0.095 |
| Previous Close | 0.090 |
| Day's Range | 0.090 - 0.110 |
| 52-Week Range | 0.029 - 0.140 |
| Beta | -0.60 |
| RSI | 49.35 |
| Earnings Date | Mar 23, 2026 |
About Tertiary Minerals
Tertiary Minerals plc, together with its subsidiaries, identifies, acquires, explores, and develops mineral properties. It explores for copper, gold, zinc, lead, tellurium, bismuth, cobalt, and silver deposits, as well as base and precious metals in Zambia and Nevada. The company was incorporated in 1999 and is headquartered in Macclesfield, the United Kingdom. [Read more]
Financial Performance
In fiscal year 2025, Tertiary Minerals's revenue was 200,569, an increase of 23.31% compared to the previous year's 162,658. Losses were -583,916, 5.99% more than in 2024.
Financial StatementsNews
AIM Market Roundup: MobilityOne, Tertiary Minerals, Corero
MobilityOne, Tertiary Minerals, Corero are today's top risers, while Trellus Health, Sancus take the biggest fall on London's AIM market
AIM Market Roundup: UK Oil & Gas, Tertiary Minerals, Pulsar Helium
UK Oil & Gas, Tertiary Minerals, Pulsar Helium are today's top risers, while Litigation Capital, Proteome Sciences take the biggest fall on London's AIM market
AIM Market Roundup: Genincode, Silver Bullet, Focusrite
Genincode, Silver Bullet, Focusrite are today's top risers, while Manolete, Tertiary Minerals take the biggest fall on London's AIM market
SMALL CAP IDEA: There is more to Tertiary Minerals than meets the eye
There is more to Tertiary Minerals than meets the eye. Certainly, far more than its current, bargain-basement valuation would suggest.
AIM Market Roundup: Dewhurst, Metir, Tertiary Minerals
Dewhurst, Metir, Tertiary Minerals are today's top risers, while LifeSafe, ImmuPharma take the biggest fall on London's AIM market